Lyell Immunopharma, Inc. Quarterly Operating Margin in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Lyell Immunopharma, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2024.
  • Lyell Immunopharma, Inc. Operating Margin for the quarter ending September 30, 2024 was -345K %, a 82534% decline year-over-year.
  • Lyell Immunopharma, Inc. annual Operating Margin for 2023 was -190K %, a 85918% decline from 2022.
  • Lyell Immunopharma, Inc. annual Operating Margin for 2022 was -221 %, a 89% increase from 2021.
  • Lyell Immunopharma, Inc. annual Operating Margin for 2021 was -2.02K %, a 26.2% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -345K -344K -82534% Jul 1, 2024 Sep 30, 2024
Q2 2024 -418K -417K -96517% Apr 1, 2024 Jun 30, 2024
Q1 2024 -353K -353K -164060% Jan 1, 2024 Mar 31, 2024
Q4 2023 -190K -190K -85918% Oct 1, 2023 Dec 31, 2023
Q3 2023 -417 +145 +25.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -433 +51.2 +10.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -215 +2.39K +91.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -221 +1.8K +89% Oct 1, 2022 Dec 31, 2022
Q3 2022 -562 Jul 1, 2022 Sep 30, 2022
Q2 2022 -484 Apr 1, 2022 Jun 30, 2022
Q1 2022 -2.6K Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.02K Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.